Drug recall · December 7, 2016
Ondansetron HCI API recall
Why: Microbial Contamination of Non-Sterile Product
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Ondansetron HCI API, Bulk, Manufacturer: Cadila Pharmaceuticals, Ltd., Ankleshwar, Gujarat, India 393002
- Lots / codes
Supplied Batch, 150N004; Exp. 08/20 Supplied Batch, 150N006; Exp. 09/20
- Quantity
- 6.0kg
- Company
- Cadila Pharmaceuticals Limited, Ankleshwar
- Distribution
- According to the firm, the API distributed to two consignees in the US. See Consignee list below. Consignee List: 1). LLC LENS Phanna. Russia 2). Claris irljectable, Ahmedabad 3). CPL. Inc, USA
- Initiated
- September 9, 2016 · Voluntary: Firm initiated
- Classified
- December 1, 2016
- Reported
- December 7, 2016
- Ended
- June 29, 2017
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Ondansetron
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.